Dementia Research Update Cornwall Research Showcase Thursday 22 nd October 2015 Dr Stephen Pearson Consultant in Older Adult Psychiatry Devon Partnership.

Slides:



Advertisements
Similar presentations
Areas of Research Specific issues. Clinical Trials Phase I First use in humans of an experimental drug or treatment In a small group of healthy volunteers.
Advertisements

NOAC but NICE Conference 16 th July An introduction Martin Stephens July 2013.
West Midlands Academic Health Science Network
West Midlands Academic Health Science Network Mental Health Clinical Priority Event October 10 th, 2013 Peter Lewis Medical Director, Birmingham and Solihull.
West Midlands Academic Health Science Network
+ The Power of Music: “music therapy and the brain” Lewelyn Fernandez University of California Merced.
Living and Dying with Dementia (a Hospital Perspective) Dr Oliver J Corrado, Consultant Geriatrician, Leeds Teaching Hospitals and LTHT ‘Dementia Champion’
Management of Early Dementia Dr Eleanor Mullan Consultant Psychiatrist Mental Health Services for Older People South Lee, Cork Feb 2011.
Improving the wider social determinants of health in Sunderland through the Exercise Referral Programme Average health status in Sunderland is poorer than.
Spending the NTW Pound Guy Pilkington. The Alliance Clinical Commissioning Groups have started a listening exercise “Deciding Together”, to look at how.
Why we need to change. What is Healthier Together? A look at the way health services are delivered Looking at services provided in hospitals Looking at.
Fylde Coast Integrated Diabetes Care
Psychological therapies – Penrith, Cumbria Alan Cohen FRCGP Senior Primary Care Advisor.
1 Alzheimer’s Disease Who is Affected? Presented by Maria C. Carrillo, Ph.D. Alzheimer’s Association December 2010.
Clinical trials with DeNDRoN in the North East Dr Margaret Piggott Data and Communications Manager Dementias and Neurodegenerative.
Better together We provide integrated mental and physical healthcare services for people of all ages. This includes specialist services such as learning.
Clinical academic training in a changing landscape. JP Neilson NIHR Dean for Training [DATE] Imperial 2011.
OPTIMISING MEDICINES USE GRAHAM DAVIES Professor of Clinical Pharmacy & Therapeutics Institute of Pharmaceutical Science King’s College London.
Dr Hugh Sturgess Executive Director Pennine MSK Partnership Ltd Implementation of STarT Back in Oldham.
Northern England Strategic Clinical Network Conference Rahul Nayar SCN – Diabetes Lead 15 th May 2015.
S D C R N Graham A Jackson Professor of Dementia Care Alzheimer Scotland Centre for Policy and Practice University West of Scotland.
1 The UK Opportunity: what is experimental medicine? UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Pre- clinical develop- ment Phase I Phase II Phase III Product.
Death with Dignity – End of Life Care in Care Homes:
Together we’re better Working in partnership with our patients, communities & GP member practices to continually improve quality of care & to support people.
Dementia Produced by Wessex LMCs in partnership with: Dr Nicola Decker, GP Alzheimer’s Society.
Dementia Friendly Communities: The National Picture Simon Kitchen, Lead Executive, Dementia Action Alliance.
Metabolic effects Diabetes
THE ROLE OF ALZHEIMER ASSOCIATIONS IN CAMPAIGNING FOR CHANGE Marc Wortmann Alzheimer’s Disease International.
A Healthy Heart What Women Need to Know By Jordan Robertson, ND.
Commissioning Intentions for 2015/16 Paul Sinden, Director of Commissioning.
13 August 2014 Dementia Services and BSC CCG Presented by Dr Andrew Coward Chair, BSC CCG.
West Cheshire PPG Monday 20 th April 2015 Chairs Meeting.
Community Health Assessment. Comprehensive analysis of total health of Stanislaus County Phase 1: Secondary data analysis Conducted during Analysis.
WHAT IS RESEARCH? Catey Bunce Principal Statistician NIHR Biomedical Research Centre (BRC) at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute.
Welcome Rebecca Wood Chief Executive. Welcome Alzheimer’s Research UK.
Professor Ken Stein Professor of Public Health University of Exeter Medical School (UEMS)
NICE Decision Making Dr Katherine Payne North West Genetics Knowledge Park The University of Manchester
Decision presented by the committee board members: Nicholas Mann & Katelyn Strasser FUTURE FUNDING FOR ALZHEIMER’S DISEASE October 14, 2014 MPH 543 Leadership.
ALZHEIMER’S PART 2. AD VIDEO
PATIENTS IN RESEARCH RESEARCH PARTNERSHIPS.
LLT dementia1 Dementia - Update and implications for Later Life Training - 1 st steps.
LISA JOHNSON & SUZANNE GRIESEL MPH 543 LEADERSHIP AND ORGANIZATIONAL BEHAVIOR FEBRUARY 16, 2014 Funding Analysis of Alzheimer’s Treatment Options: Three.
How To Improve Memory Performance and Keep Your Brain Young Gary W. Small, MD Parlow-Solomon Professor on Aging Professor of Psychiatry & Biobehavioral.
Tina Huang.  Aimed at people aged 40 – 74  Risk assessment and management programme to prevent or delay the onset of diabetes, heart and kidney disease.
Alzheimer’s Society, UK Our research programme
What’s on the Horizon Anita Corrigan Nurse Director
Medical University of Sofia, Faculty of Medicine Department of Pharmacology and Toxicology Alzheimer’s Disease Avi Gandhi (2009)
The European Innovation Partnership for asthma: an opportunity for change Samantha Walker PhD, Asthma UK Project Coordinator, EARIP (European Asthma Research.
A media webinar co-hosted by the Science Media Centre of Canada Brain stimulation therapies for mental illness.
STEPWISE: STructured lifestyle Education for People WIth SchizophrEnia Chris Dickens, Professor of Psychological Medicine University of Exeter Medical.
Access to drugs, Reducing bottlenecks Matt Cooper Business Development & Marketing Director NIHR Clinical Research Network
Module 3: Alzheimer’s Disease – What is the Role of Public Health? A Public Health Approach to Alzheimer’s and Other Dementias.
Dementia: Alzheimer’s Disease Cyril Evbuomwan Patient Group Meeting 1 st December 2015.
Women’s Heart Health: Management challenges involved in organising and delivering effective services European Health Forum in Gastein 7 October 2004 Dr.
Putting Patients at the Centre of Care What can my Community Pharmacist do for me? Dr Tarlochan Gill Chairman, Kent & Medway Pharmacy Local Professional.
Dementia Care - a Forward View and a note on the Nottinghamshire Healthcare Strategy Professor Martin Orrell Director, Institute of Mental Health 1.
NHS Health Check programme An opportunity to engage 15 million people to live well for longer Louise Cleaver National Programme Support Manager.
Welcome Lynne Goodacre.  Over view of next 2 days  Overview of internship  Group coaching  Clarity re what they are required to produce by the end.
Building the NIHR NIHR: 10 years of delivering health and care research for the nation QEII Centre, London Wednesday 18 May 2016 Professor Dame Sally C.
‘Enhancing musculoskeletal research in primary care: engaging a community musculoskeletal physiotherapy service in research studies’ Presented by : Carol.
Early Intervention in Dementia Bernie Coope Consultant Old Age Psychiatrist/Associate Medical Director/Honorary Senior Lecturer, Worcester Association.
Powys teaching Health Board: Laying the Foundations for Good Health Our approach to delivering prudent healthcare By engaging with our population, and.
A PUBLIC HEALTH APPROACH TO ALZHEIMER’S AND OTHER DEMENTIAS ALZHEIMER’S DISEASE – WHAT IS THE ROLE OF PUBLIC HEALTH?
Dementia Risk Reduction Melanie Earlam PHE 27th September 2016
Changing demographics and the impact on dementia
Indiana University-Purdue University Indianapolis, Department of Communication Studies Race and Research: Health Communication Strategies to Increase.
Psychological Wellbeing in Dementia A Northern Ireland Perspective Dr Frances Duffy Consultant Clinical Psychologist Northern Health and Social Care.
The Herbert Protocol.
1. Reduce harms from the main preventable causes of poor health
A tool for NHS Health Check trainers (Updated April 2019)
Presentation transcript:

Dementia Research Update Cornwall Research Showcase Thursday 22 nd October 2015 Dr Stephen Pearson Consultant in Older Adult Psychiatry Devon Partnership NHS Trust Dementia Speciality Lead, NIHR Clinical Research Network: South West Peninsula

NHS Constitution 08/03/12 Page 3: and through its commitment to innovation and to the promotion, conduct and use of research to improve the current and future health and care of the population.

q The Clinical Research Network: delivering research to make patients, and the NHS, better We provide the infrastructure that allows high-quality clinical research to take place in the NHS, so that patients can benefit from new and better treatments. We help researchers to set up clinical studies quickly and effectively; support the life-sciences industry to deliver their research programmes; provide health professionals with research training; and work with patients to ensure their needs are at the very centre of all research activity

14th August % rise in people taking part in dementia research During the past 12 months almost 22,000 people have taken part in research studies to tackle dementia – a 60 per cent rise according to figures published today by the National Institute for Health Research (NIHR).

Government Minister for Life Sciences, George Freeman “Dementia is a devastating condition that can have a significant impact on the lives of those affected and their families. Volunteers are essential to our battle against the disease and I’m delighted that so many people – with and without dementia – are coming forward to participate in ground-breaking new trials. There is still a long way to go but with their help we hope to find a cure or disease modifying therapy by The race is on.”

Dementia is not A little bit of forgetfulness Normal ageing Dementia is ‘The most feared illness in those older than 50 years’

Research Is Hope in Dementia

UK population: by gender and age, mid million

Prevalence of Dementia in 2013 by CCG 0.74% in Cornwall

Prevalence of Dementia in GP Practices in the South West Peninsula Region

What is to be done?

Individual-Brain Health Modifiable risk factors - vascular Exercise Weight On your bike Mediterranean type diet Mental exercise Chess/Sudoku/Bridge APOE status?

Disease Modifying Drugs Any treatment delaying the onset of AD by 5 years could half its prevalence

CURRENT DRUGS Donepezil Galanthamine Rivastigmine (Memantine) Not disease modifying - can help with symptoms ( does not improve memory) ‘May buy a little time’ Side effects nausea and abdo upset C/I Asthma, Peptic ulcer, Heart Disease

Research trials Observational Therapy intervention – physiotherapy, occupational therapy, cognitive stimulation therapy Drug Intervention Disease modifying and symptomatic trials Phase II and Phase III drug intervention trials

Dr Stephen Pearson, FRCPsych Consultant in Older Adult Psychiatry C/O Devon Partnership NHS Trust The Quay Plymouth Road TAVISTOCK PL19 8AB

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.